Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- Akamis Bio
- Study ID
- NCT02636036
- Phase
- PHASE1
- Status
- Completed
Conditions
- Colorectal Cancer
- Epithelial Tumor
- Squamous Cell Carcinoma of the Head and Neck
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- enadenotucirev — BIOLOGICAL
- nivolumab — BIOLOGICAL
Study Details
This is a Phase I multicenter, open label, nonrandomized study of enadenotucirev administered in combination with nivolumab in subjects with metastatic or advanced epithelial tumors (with focus on CRC, SCCHN, escalation phase), not responding to standard therapy.
Key Dates
- Start date
- Jan 25, 2016
- Status verified
- Nov 2021
- Primary completion
- Oct 8, 2021
- Completion
- Oct 8, 2021
Study Design
- Enrollment
- 51 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: enadenotucirev and nivolumab
Primary Outcome Measure
Incidence, nature and severity of adverse events (safety and tolerability) in study of enadenotucirev administered in combination with a PD-1 inhibitor [ Time Frame: 12 months ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arizona Cancer Center, 1515 North Campbell Ave. | Tucson | Arizona | 85724 | - |
| City of Hope Comprehensive Cancer Center, 1500 E Duarte Str. | Duarte | California | 91010 | - |
| UCLA Medical Center, 10945 Le Conte Ave, Ste. 3360 | Santa Monica | California | 90095 | - |
| Horizon Oncology Research, 1345 Unity Place, Suite 365 | Lafayette | Indiana | 47905 | - |
| Henry Ford Hospital, 2799 West Grand Blvd. | Detroit | Michigan | 48202 | - |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6307 | - |
Find similar trials in Tucson, AZ
By condition
By specialty
By research site
University of Arizona Cancer Center, 1515 North Campbell Ave.· Tucson, AZCity of Hope Comprehensive Cancer Center, 1500 E Duarte Str.· Duarte, CAUCLA Medical Center, 10945 Le Conte Ave, Ste. 3360· Santa Monica, CAHorizon Oncology Research, 1345 Unity Place, Suite 365· Lafayette, INHenry Ford Hospital, 2799 West Grand Blvd.· Detroit, MIVanderbilt-Ingram Cancer Center· Nashville, TN
Related Studies
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California